XML 56 R29.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
SCHEDULE OF OPTIONS ACTIVITY

 

  

Shares Under

Options

  

Weighted

Average

Exercise Price

per Share

  

Weighted

Average

Remaining

Life (Years)

 
Outstanding – December 31, 2023   10,244   $13.10    8.41 
Granted   34,818    7.47    9.78 
Forfeited   -    -    - 
Expired   (3)   39.20    - 
Exercised   -    -    - 
Outstanding – December 31, 2024   45,059    3.50    9.24 
Exercisable – December 31, 2024   45,059    3.50    9.24 
SCHEDULE OF FAIR VALUE ASSUMPTIONS FOR OPTIONS GRANTED

The fair value for options granted in 2024 and 2023 is estimated at the date of grant using a Black-Scholes-Merton options pricing model with the following underlying assumptions:

 

   2024   2023 
Price at valuation   $ 6.719.90    $ 13.2 13.64 
Exercise price   $ 6.719.90    $ 13.213.64 
Risk free interest   4.144.42 %    3.83 4.42 % 
Expected term (in years)   5    5 
Volatility   128.4132.8 %    133.1 133.6 % 
SCHEDULE OF STOCK BASED EXPENSES RECOGNIZED SERVICES FROM EMPLOYEES AND NON-EMPLOYEES

The total stock-based expense recognized in the financial statements for services received from employees and non-employees is shown in the following table.

 

   2024   2023 
   Year Ended 
   December 31, 
   2024   2023 
         
Research and development  $5,000   $6,000 
Selling and marketing   17,000    28,000 
General and administrative   334,000    259,000 
Total  $356,000   $293,000 
SCHEDULE OF FAIR VALUE ASSUMPTIONS FOR WARRANTS

In estimating the warrants’ fair value, the Company used the following assumptions:

 

   2024   2023 
Risk free interest   -%   3.49%
Dividend yield   -%   -%
Volatility   -%   147.6%
Contractual term (in years)   -    5